264 related articles for article (PubMed ID: 26011400)
21. No tumour-initiating risk associated with scAAV transduction in newborn rat liver.
Gauttier V; Pichard V; Aubert D; Kaeppel C; Schmidt M; Ferry N; Conchon S
Gene Ther; 2013 Jul; 20(7):779-84. PubMed ID: 23364314
[TBL] [Abstract][Full Text] [Related]
22. A Hybrid Adenoviral Vector System Achieves Efficient Long-Term Gene Expression in the Liver via piggyBac Transposition.
Smith RP; Riordan JD; Feddersen CR; Dupuy AJ
Hum Gene Ther; 2015 Jun; 26(6):377-85. PubMed ID: 25808258
[TBL] [Abstract][Full Text] [Related]
23. A piggyBac transposon- and gateway-enhanced system for efficient BAC transgenesis.
Zhao L; Ng ET; Koopman P
Dev Dyn; 2014 Sep; 243(9):1086-94. PubMed ID: 24924516
[TBL] [Abstract][Full Text] [Related]
24. Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors.
Recchia A; Perani L; Sartori D; Olgiati C; Mavilio F
Mol Ther; 2004 Oct; 10(4):660-70. PubMed ID: 15451450
[TBL] [Abstract][Full Text] [Related]
25. Incorporation of calcium phosphate enhances recombinant adeno-associated virus-mediated gene therapy in diabetic mice.
Yang YW; Chao CK
J Gene Med; 2003 May; 5(5):417-24. PubMed ID: 12731090
[TBL] [Abstract][Full Text] [Related]
26. Hyperactive piggyBac transposons for sustained and robust liver-targeted gene therapy.
Di Matteo M; Samara-Kuko E; Ward NJ; Waddington SN; McVey JH; Chuah MK; VandenDriessche T
Mol Ther; 2014 Sep; 22(9):1614-24. PubMed ID: 25034357
[TBL] [Abstract][Full Text] [Related]
27. Adeno-associated virus vectors as therapeutic and investigational tools in the cardiovascular system.
Zacchigna S; Zentilin L; Giacca M
Circ Res; 2014 May; 114(11):1827-46. PubMed ID: 24855205
[TBL] [Abstract][Full Text] [Related]
28. Long-term enzymatic and phenotypic correction in the phenylketonuria mouse model by adeno-associated virus vector-mediated gene transfer.
Oh HJ; Park ES; Kang S; Jo I; Jung SC
Pediatr Res; 2004 Aug; 56(2):278-84. PubMed ID: 15181195
[TBL] [Abstract][Full Text] [Related]
29. Administration-route and gender-independent long-term therapeutic correction of phenylketonuria (PKU) in a mouse model by recombinant adeno-associated virus 8 pseudotyped vector-mediated gene transfer.
Ding Z; Georgiev P; Thöny B
Gene Ther; 2006 Apr; 13(7):587-93. PubMed ID: 16319947
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models.
Davidoff AM; Gray JT; Ng CY; Zhang Y; Zhou J; Spence Y; Bakar Y; Nathwani AC
Mol Ther; 2005 Jun; 11(6):875-88. PubMed ID: 15922958
[TBL] [Abstract][Full Text] [Related]
31. Recombinant adeno-associated virus vector: Is it ideal for gene delivery in liver transplantation?
Yang ZF; Wu XB; Tsui TY; Hou YD; Luk JM; Fan ST
Liver Transpl; 2003 Apr; 9(4):411-20. PubMed ID: 12682895
[TBL] [Abstract][Full Text] [Related]
32. A new method for recombinant adeno-associated virus vector delivery to murine diaphragm.
Mah C; Fraites TJ; Cresawn KO; Zolotukhin I; Lewis MA; Byrne BJ
Mol Ther; 2004 Mar; 9(3):458-63. PubMed ID: 15006614
[TBL] [Abstract][Full Text] [Related]
33. Correction of argininosuccinate synthetase (AS) deficiency in a murine model of citrullinemia with recombinant adenovirus carrying human AS cDNA.
Ye X; Whiteman B; Jerebtsova M; Batshaw ML
Gene Ther; 2000 Oct; 7(20):1777-82. PubMed ID: 11083500
[TBL] [Abstract][Full Text] [Related]
34. Transient depletion of CD4 lymphocyte improves efficacy of repeated administration of recombinant adenovirus in the ornithine transcarbamylase deficient sparse fur mouse.
Ye X; Robinson MB; Pabin C; Batshaw ML; Wilson JM
Gene Ther; 2000 Oct; 7(20):1761-7. PubMed ID: 11083498
[TBL] [Abstract][Full Text] [Related]
35. PiggyBac transposase and transposon derivatives for gene transfer targeting the ribosomal DNA loci of CHO cells.
Bire S; Dusserre Y; Bigot Y; Mermod N
J Biotechnol; 2021 Nov; 341():103-112. PubMed ID: 34560160
[TBL] [Abstract][Full Text] [Related]
36. Toll-like receptor 2-mediated innate immune response in human nonparenchymal liver cells toward adeno-associated viral vectors.
Hösel M; Broxtermann M; Janicki H; Esser K; Arzberger S; Hartmann P; Gillen S; Kleeff J; Stabenow D; Odenthal M; Knolle P; Hallek M; Protzer U; Büning H
Hepatology; 2012 Jan; 55(1):287-97. PubMed ID: 21898480
[TBL] [Abstract][Full Text] [Related]
37. Adenoviral vectors for liver-directed gene therapy.
Connelly S
Curr Opin Mol Ther; 1999 Oct; 1(5):565-72. PubMed ID: 11249663
[TBL] [Abstract][Full Text] [Related]
38. Generation of recombinant adeno-associated virus (rAAV) from an adenoviral vector and functional reconstitution of the NADPH-oxidase.
Thrasher AJ; de Alwis M; Casimir CM; Kinnon C; Page K; Lebkowski J; Segal AW; Levinsky RJ
Gene Ther; 1995 Sep; 2(7):481-5. PubMed ID: 7584126
[TBL] [Abstract][Full Text] [Related]
39. Generation of non-viral, transgene-free hepatocyte like cells with piggyBac transposon.
Katayama H; Yasuchika K; Miyauchi Y; Kojima H; Yamaoka R; Kawai T; Yukie Yoshitoshi E; Ogiso S; Kita S; Yasuda K; Sasaki N; Fukumitsu K; Komori J; Ishii T; Uemoto S
Sci Rep; 2017 Mar; 7():44498. PubMed ID: 28295042
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of muscle gene delivery with pseudotyped adeno-associated virus type 5 correlates with myoblast differentiation.
Duan D; Yan Z; Yue Y; Ding W; Engelhardt JF
J Virol; 2001 Aug; 75(16):7662-71. PubMed ID: 11462038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
